Literature DB >> 948350

Interaction of hexafluorenium with human plasma cholinesterase in comparison with hexamethonium.

F R Schuh.   

Abstract

1. The influence of the 2 alkane-bis-onium compounds hexafluorenium (HF1) and hexamethonium (C6) on human plasma cholinesterase (ChE) was studied with respect to the type of inhibition. 2. HF1 and C6 are reversible inhibitors of ChE. The inhibitory potency of HF1 (pI50 = 6.96; Ki = 2.4 x 10(-9)) is about 40 000-fold higher than that of C6 (pI50 = 2.4; Ki = 6.7 x 10(-2)). 3. The kinetic analysis displayed a competitive (C6) and a non-competitive (hf1) mechanism of action. 4. The inhibition of ChE by C6 is induced by a binding of C6 to the anionic site of the active center thus impairing the primary formation of the enzyme-substrate complex. HF1, however, is most probably bound to anionic side receptors in the vicinity of the active center; by that a conformational change of the enzyme protein is induced impairing the acylation step of the esteratic site.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 948350     DOI: 10.1007/bf00498865

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  8 in total

1.  Hexafluorenium: its anticholinesterase and neuromuscular activity.

Authors:  F F FOLDES; R E MOLLOY; E K ZSIGMOND; J A ZWARTZ
Journal:  J Pharmacol Exp Ther       Date:  1960-08       Impact factor: 4.030

2.  Potentiation of the neuromuscular effect of succinylcholine by hexafluorenium.

Authors:  F F FOLDES; N R HILLMER; R E MOLLOY; A P MONTE
Journal:  Anesthesiology       Date:  1960 Jan-Feb       Impact factor: 7.892

3.  Pseudocholinesterase activity of human whole blood, bank blood, and blood protein solutions.

Authors:  F T Schuh
Journal:  Anaesthesist       Date:  1975-03       Impact factor: 1.041

Review 4.  Hexafluorenium bromide: current status and a review.

Authors:  R M Britton; M Figueroa
Journal:  Anesth Analg       Date:  1973 Jan-Feb       Impact factor: 5.108

5.  Influence of alkane-bis-onium compounds upon the activity of the AchE and upon its inhibition by DFP.

Authors:  H Lüllmann; F K Ohnesorge; H D Tonner; O Wassermann; A Ziegler
Journal:  Biochem Pharmacol       Date:  1971-10       Impact factor: 5.858

6.  Guanylhydrazones, another class of monoamine oxidase inhibitors.

Authors:  E Mutschler; J Springer; O Wassermann
Journal:  Biochem Pharmacol       Date:  1970-01       Impact factor: 5.858

7.  [A kinetic method for determination of the activity of pseudocholinesterase (acylcholine acyl-hydrolase 3.1.1.8.)].

Authors:  M Knedel; R Böttger
Journal:  Klin Wochenschr       Date:  1967-03-15

8.  Influence of ketamine on human plasma cholinesterase.

Authors:  F T Schuh
Journal:  Br J Anaesth       Date:  1975-12       Impact factor: 9.166

  8 in total
  1 in total

1.  Cholinergic control of gastric acid secretion.

Authors:  F Pagani; A Brambilla; A Schiavone; A Giachetti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-03       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.